Problems in how the way research is generated, published, interpreted, and used affect toxicology as much as any other scientific discipline. There are increasingly large numbers of papers using questionable methods, getting through peer-review without sufficiently rigorous checks, that are being interpreted into policy using outdated approaches for synthesising evidence.
The Evidence-Based Toxicology Collaboration (www.ebtox.org) was established in 2011 to raise research standards in toxicology. In 2023, we are pleased to announce EBTC 2.0, a new bottom-up model for researchers, industry, publishers, and NGOs to collaborate in improving the conduct, use, and publication of toxicological research.
EBTC 2.0 is based on four pillars and is launching a new journal to introduce cutting-edge publishing practices to toxicology.
- Developing and promoting new best-practice standards for conducting, reporting, and assessing the quality of toxicological research
- Using systematic methods for synthesising and mapping toxicological evidence, to make sense of omplex and contradictory evidence
- Improving access to research through open science practices, promotion of FAIR data, and the use of AI in research
- Designing evidence-to-decision frameworks to improve the integration of evidence into policy-making
Key to the new collaboration model is EBTC's journal, Evidence-Based Toxicology (https://www.tandfonline.com/journals/tebt20). The first toxicology journal to adopt recent moves toward publish-review-curate models of research publishing, and implementing radical transparency in an open peer-review process, EBT seeks to lead the field in reinventing publishing to support the goals of EBTC.
These are exciting times for scientific publishing. Contact Paul Whaley, PhD, for more information.
Cell: +44 (0) 7529 717 737